| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b7f2004ca65113cb8b98f4485e30358
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bba710e7aaa56d8ab15a910fcd3dc5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ffdafc26799ef67e1a5bcd203871f39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd203f4fa6949103ad1153d7fa714c94 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B40-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-24 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B40-30 |
| filingDate |
2012-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_edb92616c4187bf2416f51b423bb91be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_090e4f543476f6f7dad3660927700065
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36c92b2cfd69a2b5f07ab78a4d1bf5a8 |
| publicationDate |
2014-04-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014113978-A1 |
| titleOfInvention |
Multifocal hepatocellular carcinoma microrna expression patterns and uses thereof |
| abstract |
The present invention is directed to methods and products for defining a biomarker of disease phenotype. The present invention further relates to methods and kits for determining a subject's risk of developing recurrent hepatocellular carcinoma based on a defined microRNA biomarker that reliably distinguishes hepatocellular carcinoma disease recurrence from non-recurrence. The invention also relates to methods of treating a patient having heptocellular carcinoma based on their risk of developing hepatocellular carcinoma disease recurrence. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021215475-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021527448-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020058472-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11339440-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018179514-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210057065-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019169304-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102339206-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112867802-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015313963-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7045527-B2 |
| priorityDate |
2011-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |